Denali Therapeutics Inc

NASDAQ:DNLI   3:59:57 PM EDT
60.52
-0.50 (-0.82%)
Products

Denali Therapeutics Says First Human Biomarker Proof Of Concept For Its Transport Vehicle Technology Achieved In Study of ETV:IDS (DNL310)

Published: 11/10/2020 12:46 GMT
Denali Therapeutics Inc (DNLI) - Denali Therapeutics Announces First Human Biomarker Proof of Concept for Its Transport Vehicle (tv) Technology Achieved in Phase 1/2 Study of Etv:ids (dnl310) in Hunter Syndrome (mps Ii).
Denali Therapeutics - Based on Cohort a Safety Data Review, Independent Data Monitoring Committee Recommended Continuing Study Without Modifications.